| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Richard Mejia Jr. last filed a Form 4 in June 2021, as Director at VTAK. Richard Mejia Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 21,946 shares of VTAK. Net of sales, the VTAK filings show accumulation of 51,000 shares.
Richard Mejia Jr. has 8 Form 4 filings on record from October 2018 to June 2021, all as Director at Catheter Precision (VTAK), 2018–2021.
The 8 reported transactions were 5 stock awards, 2 open-market purchases and 1 option or other derivative award.
Counted by filing, the open-market trades come to 2 purchases worth about $36K and no sales.
The largest open-market purchase was 50,000 shares of VTAK at an average $0.60 on June 12, 2020, about $30K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.